Rapid development of nitric oxide-induced hyperalgesia depends on an alternate to the cGMP-mediated pathway in the rat neuropathic pain model

Brain Research

Volumn 792, Issue 2, 1998, Pages 263-270

  Inoue, Takaya ^a   Mashimo, Takashi ^a   Shibata, Masahiko ^a   Shibuta, Satoshi ^a   Yoshiya, Ikuto ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Cyclic GMP; Hyperalgesia; Nerve injury; Nitric oxide; NO releasing compound; Spinal cord

Indexed keywords

3,3 BIS(2 AMINOETHYL) 1 HYDROXY 2 OXOTRIAZENE; CYCLIC GMP; DIZOCILPINE; GUANYLATE CYCLASE INHIBITOR; HEMOGLOBIN; METHYLENE BLUE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; HEAT TOLERANCE; HYPERALGESIA; MALE; NEUROPATHY; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; STIMULUS RESPONSE;

ANIMALS; ANTIDOTES; CYCLIC GMP; DISEASE MODELS, ANIMAL; DIZOCILPINE MALEATE; ENZYME INHIBITORS; EXCITATORY AMINO ACID ANTAGONISTS; HEAT; HEMOGLOBINS; HYPERALGESIA; LIGATION; MALE; METHYLENE BLUE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITROSO COMPOUNDS; PAIN; RATS; RATS, SPRAGUE-DAWLEY; SCIATIC NERVE; SPINAL CORD;

EID: 0032507691     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00147-4     Document Type: Article

References (58)

1. Aanonsen L.M., Lei S., Wilcox G.L. Excitatory amino acid receptors and nociceptive neurotransmission in rat spinal cord. Pain. 41:1990;309-321.
2. Attal N., Jazat F., Kayser V., Guilbaud G. Further evidence for 'pain-related' behaviors in a model of unilateral peripheral mononeuropathy. Pain. 41:1990;235-251.
3. Basbaum A.I., Gautron M., Jazat F., Mayes M., Guilbaud G. The spectrum of fiber loss in a model of neuropathic pain in the rat: an electron microscopic study. Pain. 47:1991;359-367.
4. Bates J.N., Baker M.T., Guerra R.J., Harrison D.G. Nitric oxide generation from nitroprusside by vascular tissue. Biochem. Pharmacol. 42:1991;S157-S165.
5. Bennett G.J., Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 33:1988;87-107.
6. Bolotina V.M., Najibi S., Palacino J.J., Pagano P.J., Cohen R.A. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature. 368:1994;850-853.
7. Bredt D.S., Snyder S.H. Nitric oxide, a novel neuronal messenger. Neuron. 8:1992;3-11.
8. Bult H., Boeckxstaens G.E., Pelckmans P.A., Jordaens F.H., Van maercke Y.M., Herman A.G. Nitric oxide as an inhibitory non-adrenergic non-cholinergic neurotransmitter. Nature. 345:1990;346-347.
9. Cahusac P.M.B., Evans R.H., Hill R.G., Rodriguez R.E., Smith D.A.S. The behavioral effects of an N-methylaspartate receptor antagonist following application to the lumbar spinal cord of conscious rats. Neuropharmacology. 23:1984;719-724.
10. Coderre T.J. The role of excitatory amino acid receptors and intracellular messengers in persistent nociception after tissue injury in rats. Mol. Neurobiol. 7:1993;229-246.
11. Coderre T.J., Katz J., Vaccarino A.L., Melzack R. Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain. 52:1993;259-285.
12. Davar G., Hama A., Deykin A., Vos B., Maciewicz R. MK-801 blocks the development of thermal hyperalgesia in a rat model of experimental painful neuropathy. Brain Res. 553:1991;327-330.
13. Deguchi T. Endogenous activating factor for guanylate cyclase in synaptosomal-soluble fraction of rat brain. J. Biol. Chem. 252:1977;7617-7619.
14. Dubner R., Ruda M.A. Activity-dependent neuronal plasticity following tissue injury and inflammation. Trends Neurosci. 15:1992;96-103.
15. Feelish M., Noack E.A. Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase. Eur. J. Pharmacol. 139:1987;19-30.
16. Fesenko E.E., Kolesnikov S.S., Lyubarsky A.L. Induction by cyclic GMP of cationic conductance in plasma membrane of retinal rod outer segment. Nature. 313:1985;310-313.
17. Garthwaite J., Charles S.L., Chess-Williams R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature. 336:1988;385-388.
18. Garthwaite J. Glutamate, nitric oxide and cell-cell signaling in the nervous system. Trends Neurosci. 14:1991;60-67.
19. Gerber G., Randic M. Participation of excitatory amino acid receptors in the slow excitatory synaptic transmission in the rat spinal cord in vitro. Neurosci. Lett. 106:1989;220-228.
20. Gibson A., Mirzazadeh S., Hobbs A.J., Moore P.K. L-NG-Monomethyl arginine and L-NG-nitro arginine inhibit non-adrenergic non-cholinergic relaxation of the mouse anococcygeus muscle. Br. J. Pharmacol. 99:1990;602-606.
21. Hrabie J.A., Klose J.R., Wink D.A., Keefer L.K. New nitric oxide-releasing zwitterions derived from polyamines. J. Org. Chem. 58:1993;1472-1476.
22. Ignarro L.J. Nitric oxide: a novel signal transduction mechanism for transcellular communication. Hypertension. 16:1990;477-483.
23. Inoue T., Mashimo T., Shibuta S., Yoshiya I. Intrathecal administration of a new nitric oxide donor, NOC-18, produces acute thermal hyperalgesia in the rat. J. Neurol. Sci. 153:1997;1-7.
24. Irwin S., Houde R.W., Bennett D.R., Hendershot L.C., Seevers M.H. The effect of morphine, methadone and meperidine on some reflexes of spinal animals to nociceptive stimulation. J. Pharmacol. Exp. Ther. 101:1951;132-143.
25. Katayama Y. NOC. Dojin. News. 69:1994;21.
26. Kawabata A., Umeda N., Takagi H. L-Arginine exerts a dual role in nociceptive processing in the brain: involvement of the kyotorphine-Met-enkephalin pathway and NO-cyclic GMP pathway. Br. J. Pharmacol. 109:1993;73-79.
27. King A.E., Thompson S.W.N., Urban L., Woolf C.J. An intracellular analysis of amino acid induced excitations of deep dorsal horn neurones in the rat spinal cord slice. Neurosci. Lett. 89:1988;286-292.
28. Kitto K.F., Haley J.E., Wilcox G.L. Involvement of nitric oxide in spinally mediated hyperalgesia in the mouse. Neurosci. Lett. 148:1992;1-5.
29. Knowles R.G., Palacios M., Palmar R.M.J., Moncada S. Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase. Proc. Natl. Acad. Sci. U.S.A. 86:1989;5159-5162.
30. Kolhekar R., Murphy S., Gebhart G.F. Thalamic NMDA receptors modulate inflammation-produced hyperalgesia in the rat. Pain. 71:1997;31-40.
31. Lepoivre M., Fieschi F., Coves J., Thelander L., Fontecave M. Inactivation of ribonucleotide reductase by nitric oxide. Biochem. Biophys. Res. Commun. 179:1991;442-448.
32. Meller S.T., Dykstra C., Gebhart G.F. Production of endogenous nitric oxide and activation of soluble guanylate cyclase are required for N-methyl-D-aspartate-produced facilitation of the nociceptive tail-flick reflex. Eur. J. Pharmacol. 214:1992;93-96.
33. Meller S.T., Pechman P.S., Gebhart G.F., Maves T.J. Nitric oxide mediates the thermal hyperalgesia produced in a model of neuropathic pain in the rat. Neuroscience. 50:1992;7-10.
34. Meller S.T., Gebhart G.F. Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain. 52:1993;127-136.
35. Miki N., Kawabe Y., Kuriyama K. Activation of cerebral guanylate cyclase by nitric oxide. Biochem. Biophys. Res. Commun. 75:1977;851-856.
36. Moncada S., Palmar R.M.J., Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:1991;109-142.
37. Palmar R.M.J., Ferrige A.G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 327:1987;524-526.
38. Pastoriza L.M., Morrow T.J., Casey K.L. Medial frontal cortex lesions selectively attenuate the hot plate response: possible nocifensive apraxia in the rat. Pain. 64:1996;11-17.
39. 2+ current increase in snail neurons. Nature. 323:1986;812-814.
40. Raigorodsky G., Urca G. Intrathecal N-methyl-D-aspartate (NMDA) activates both nociceptive and antinociceptive systems. Brain Res. 422:1987;158-162.
41. Shibuki K., Okada D. Endogenous nitric oxide release required for long-term synaptic depression in the cerebellum. Nature. 349:1991;326-328.
42. M. Shibata, S. Wakisaka, T. Inoue, T. Shimizu, I. Yoshiya, The effect of electroconvulsive treatment on thermal hyperalgesia and mechanical allodynia in a rat model of peripheral neuropathy, Anesth. Analg. (in press).
43. Shibuta S., Mashimo T., Ohara A., Zhang P., Yoshiya I. Intracerebroventricular administration of a nitric oxide-releasing compound, NOC-18, produces thermal hyperalgesia in rats. Neurosci. Lett. 187:1995;103-106.
44. Shibuta S., Mashimo T., Zhang P., Ohara A., Yoshiya I. A new nitric oxide donor, NOC-18, exhibits a nociceptive effect in the rat formalin model. J. Neurol. Sci. 141:1996;1-5.
45. Shiga T., Hwang K.J., Tyuma I. Electron paramagnetic resonance studies of nitric oxide hemoglobin derivatives: I. Human hemoglobin subunits. Biochemistry. 8:1969;378-383.
46. Shimaoka M., Iida T., Ohara A., Taenaka N., Mashimo T., Honda T., Yoshiya I. NOC, a nitric-oxide-releasing compound, induces dose dependent apoptosis in macrophases. Biochem. Biophys. Res. Commun. 209:1995;519-526.
47. Smith G.D., Harrison S.M., Birch P.J. Peri-administration of clonidine or MK-801 delays but does not prevent the development of mechanical hyperalgesia in a model of mononeuropathy in the rat. Neurosci. Lett. 192:1995;33-36.
48. Snyder S.H., Bredt D.S. Nitric oxide as a neural messenger. Trends Pharmacol. Sci. 12:1991;125-128.
49. Snyder S.H. Nitric oxide: first in a new class of neurotransmitters. Science. 257:1992;494-496.
50. Tseng L.F., Xu J.Y., Pieper G.M. Increasing of nitric oxide production by L-arginine potentiates i.c.v. administered β-endorphin-induced antinociception in the mouse. Eur. J. Pharmacol. 212:1992;301-303.
51. Tucker J.F., Brave S.R., Charalambous L., Hobbs A.J., Gibson A. L-NG-nitro arginine inhibits non-cholinergic relaxation of guinea pig trachea. Br. J. Pharmacol. 100:1990;663-664.
52. Vocci F.J., Petty S.K., Dewey W.L. Antinociceptive action of the butyryl derivatives of cyclic guanosine 3′,5′-monophosphate. J. Pharmacol. Exp. Ther. 207:1978;892-898.
53. Woolf C.J., Thompson S.W.N. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation: implications for the treatment of post-injury pain hypersensitivity states. Pain. 44:1991;293-299.
54. C.J. Woolf, Excitability changes in central neurons following peripheral damage: the role of central sensitization in the pathogenesis of pain, in: W.D. Willis (Ed.), Hyperalgesia and Allodynia, Raven Press, New York, 1992, pp. 221-244.
55. Yaksh T.L., Rudy T.A. Chronic catheterization of the spinal subarachnoid space. Physiol. Behav. 17:1976;1031-1036.
56. Yamamoto T., Shimoyama N., Mizuguchi T. Role of the injury discharge in the development of thermal hyperesthesia after sciatic nerve constriction injury in the rat. Anesthesiology. 79:1993;993-1002.
57. Yamamoto T., Shimoyama N. Role of nitric oxide in the development of thermal hyperesthesia induced by sciatic nerve constriction injury in the rat. Anesthesiology. 82:1995;1266-1273.
58. Zhang P., Ohara A., Mashimo T., Sun J., Shibuta S., Takada K., Kosaka H., Terada M., Yoshiya I. Cardiovascular effects of an ultra-short acting nitric oxide-releasing compound, zwitterionic diamine/NO adduct, in dogs. Circulation. 94:1996;2235-2240.